Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Robert I. Haddad(Georgetown University), Arnold M. Markoe(University of Miami), Luis E. Raez(Florida International University), Sergei Tjulandin, Berta Roth, C. Blajman, Diáne Hershock(Sanofi (United States)), Rosana del Carmen Viroglio, E. Mickiewicz, Eric Winquist(Western University), Anthony J. Cmelak(Breast Cancer Research Foundation), Lynn M. Steinbrenner(VA Western New York Healthcare System), Thomas J. Ervin(Bayfront Medical Center), Sanjiv S. Agarwala(Goethe University Frankfurt), Charles M. Norris, A. Dimitrios Colevas(Cancer Institute (WIA)), И. С. Романов(Russian Cancer Research Center NN Blokhin), Roy B. Tishler(Dana-Farber Cancer Institute), Barbara A. Murphy(Vanderbilt University), Paul W. Read(University of Virginia Health System), Varagur Venkatesan(Western University), Roger B. Cohen(University of Pennsylvania), Kevin J. Cullen(University of Maryland, Baltimore), Monica B. Spaulding(VA Western New York Healthcare System), K. William Harter(Vince Lombardi Cancer Clinic), Vera Gorbounova(Russian Cancer Research Center NN Blokhin), Matthew Dugan(Center for Cancer and Blood Disorders), Dong M. Shin(Emory University)
Cited by 1,704
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k